The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.
As companies race to find a vaccine for COVID-19, many have wondered how effective an eventual vaccine will be, how quickly it can be produced at scale, and how it can be distributed equitably around the globe.
Ariadne Labs' Vaccine Delivery efforts are focused on addressing these questions and identifying solutions to ensure that countries worldwide benefit from the advent of a vaccine.
Anthony McDonnell, Robert Van Exan, Kalipso Chalkidou, Julie Rosenberg, Rebecca Weintraub, and Prashant Yadav Much of the discussion around society’s ability to return to “normality” after the COVID-19 pandemic has...
Dr. Rebecca Weintraub on the need for global COVID-19 vaccine initiative.
The second part of a three-part Netflix series, “Coronavirus, Explained,” features Rebecca Weintraub, MD, the director of Ariadne Labs’ Better Evidence Program, speaking on the issue of...
Dr. Rebecca Weintraub is quoted from her article on the issue of vaccine nationalism.
Rebecca Weintraub speaks with Maclean's about the need to ensure equitable vaccine delivery.